We 
tissue culture model and In HIV-infected people. We show that increased levels of Tat, but not Rev, can release the proviruses from latency in U1 cells. The absence of Tat in these cells is manifested by the accumulation of promoter-proximal viral transcripts, whereas the presence of Tat correlates with increased expression of viral proteins and an increase in promoter-distal tnscripts. The presence of promoter-proximal transcripts also serves as a marker for latency in humans. We observed the exclusive presence of promoter-proximal viral transcripts in peripheral mononuclear cells from the majiority (10/11) of asymptomatic IlV-infected individuals examined. Activation of these cells in vigro, and viremia in vivo, correlated with a switch from promoter-proimal anscription to promoter-distal ascription. These results suggest that the control between latency and replication ofHIV in vivo is at the level of transcription elongation.
Although the progression from sero-conversion to the acquired immunodeficiency syndrome (AIDS) frequently takes years, viral replication occurs at all stages of the infection (1) (2) (3) (4) . In particular, high levels of virus can be detected in lymph nodes during the asymptomatic stages of disease progression (4, 5) . Nonetheless, the fact that there is persistent replication of human immunodeficiency virus (HIV) even in stages of clinical latency does not mean that individual cells do not harbor latent proviruses (called "cellular latency"). Indeed, individual infected cells harbor proviruses that are not expressed until further cellular activation (6) (7) (8) .
Moreover, large numbers of latently infected cells can be detected both in lymph nodes (5) and in the blood before the actual onset of AIDS (4) .
U1 cells (9) have been used as a convenient tissue culture model of HIV-1 latency because their proviruses are poorly expressed until cellular activation by a number of cytokines/ lymphokines or phorbol esters that act through the cellular transcription factor NF-#cB (reviewed in ref. 10 ). U1 cells are derived from U937 cells, which represent immature human CD4-positive monocytes (11) , and contain two integrated HIV-1 proviruses.
Here, we find that constitutive expression of the viral protein Tat induces the expression of all major viral transcripts and proteins in U1 cells, whereas the viral protein Rev has no effect. This suggests that U1 cells are held in latency because of a lack of Tat protein. We (15) . Open boxes represent the LTRs; black boxes represent the simian virus 40 early promoter, striped boxes are either the tat cDNA or the rev cDNA, and NEO is the G418-resistance gene. There was a 50-fold increase in chloramphenicol acetyltransferase activity in U937 cells infected with LTatSN compared with U937 cells infected with LXSN when both were transiently transfected with a plasmid containing an HIV-1 LTR 5' to the cat gene. There was a >200-fold increase in p24P8 in U937 cells infected with LrevSN compared with U937 cells infected with LneoSN when both were transiently transfected with a HIV-1 provirus containing a frame-shift mutation in the second exon ofRev. The amplified product of primer pairs 1 and 2 was 59 bp in length and the product of primer pairs 1 and 3 was 182 bp in length. Amplified products were detected by liquid hybridization as described (13) . Each sample was separately amplified but electrophoresed in 10%o nondenaturing polyacrylamide gels and hybridized together in the same lanes for ease of comparison. The radiolabeled probe was complementary to the TAR loop region of the HIV-1 LTR: TAR loop probe, GCCTGGGAGCTCTCTGG (positions 27-43).
The probe was end-labeled with [y-<32P]ATP and added to a final concentration of 30 pmol to samples that were denatured for 1 min at 950C and hybridized for 3 min at 56°C. Some samples were done by an alternative protocol that has equal sensitivity and specificity but is more rapid. Briefly, simultaneous RNA and DNA isolation was done using a Snap-o-sol RNA/DNA isolation kit (Biotecx Labo- ratories, Houston), and RNA samples were treated with DNase I. Primer 1 (above) was end-labeled with [y-32P]ATP and gel purified. The PCR Gem-mediated hot-start technique (Perkin-Elmer) was used to increase the specificity of the amplification. PCR reactions were carried out for 25 cycles, and one-fifth of the products were loaded on a 8% denaturing polyacrylamide gel that was run at 25 mA for 2 hr, dried, and exposed to film. Negative controls without RT were performed for all samples in addition to an RNA standard.
RESULTS
Tat Expression Induces the HIV-1 Proviruses in U1 Cells in the Absence of Cellular Activation. To gain insight into the molecular basis of latency in HIV-infected people, we first investigated a tissue culture model of cellular latency. The activation of U1 cells by phorbol esters has been shown to increase levels of total viral RNA and especially of larger singly spliced and unspliced viral transcripts (14) . To determine if the maintenance of proviral latency in U1 cells is due to insufficient levels of a viral gene product, specifically Tat or Rev, we tested whether or not the increased expression of Tat or Rev from heterologous promoters could induce these proviruses in U1 cells. To this end, retroviral vectors that expressed either Tat or Rev of HIV-1 were constructed using the genome of the murine leukemia virus (MuLV) (Fig. 1) . High titer viral stocks were obtained that could infect human epithelial and lymphoid cell lines and transfer functional Tat or Rev into these cells ( Fig. 1 and ref. 15 ).
After infection with retroviral vectors that contained Tat or Rev, viral replication was assessed by measuring levels of secreted p24w in culture supernatants of U1 cells ( Fig. 2A) . Some cultures were also infected with wild-type amphotropic MuLV to control for possible effects of MuLV proteins (Fig.  2) . Infections of U1 cells with the wild-type MuLV and the retroviral vector encoding Rev did not increase levels of p24Pm ( Fig. 2A) . On the other hand, infections with the retroviral vector encoding Tat led to rapid and sustained increases in levels of p24w. By day 8 after infection, these levels were 100-fold higher than in the control U1 cells and were nearly equivalent to that observed with PMA ( Fig. 2A) .
Uninfected U1 cells express small amounts of doubly spliced viral mRNAs (Fig. 2B, lane 1) . We found that Tat alone increased the total amounts of viral RNA and increased levels of singly spliced and genomic viral transcripts relative to those of doubly spliced mRNAs (Fig. 2B, lane 2 other hand, the quantity and splicing patterns of these mRNAs did not change when rev or neo genes were introduced into these cells (Fig. 2A, lanes 3 and 4) . These data indicate that constitutive expression of Tat induces the expression of integrated proviruses and can substitute for cellular activation of U1 cells. Thus, the previously observed phenotype of increased expression of singly spliced and genomic viral transcripts that followed cellular activation of U1 cells (14) probably reflected the increased synthesis of Rev that occurred after sufficiently high levels of Tat were achieved.
The presence of functional Tat in activated and nonactivated U1 cells was indirectly assayed by fusing U1 cells with polyethylene glycol to an indicator cell line that contained a single integrated copy of the HIV-1 LTR linked to the P-galactosidase reporter gene that is sensitive to levels of Tat (16) . The results of these experiments (not shown) demonstrated that nonactivated U1 cells express little Tat but that cellular activation increases the synthesis of Tat. This suggests that activation of U1 cells by phorbol esters acts, at least in part, through increasing Tat levels.
Tat Affects the Ratio of Promoter-Proximal to PromoterDistal Viral Transcripts in Ul Cells. Nuclear run-on experiments demonstrated a steep polarity of HIV-1 transcription from the LTR that was reversed by Tat (17) (18) (19) (20) . These transcriptional states were reflected in the accumulation of short, prematurely terminated TAR transcripts in the absence of Tat and of long polyadenylylated viral transcripts in the presence ofTat (18, 21) . Given our results that insufficient levels of Tat were indicative of proviral latency in U1 cells (Fig. 2) , we tested whether these different viral RNAs could be used as markers for proviral latency.
To determine levels of short and long viral transcripts, we used quantitative RT-PCR (12, 13). First, pairs ofprimers that corresponded to 5' and 3' ends of TAR (primers 1 and 2) and to the 3' end of the U5 region (primer 3) were synthesized (Fig. 3A) . Primers 1 and 2 would amplify both short and long transcripts, while primers 1 and 3 would amplify only RNA that was longer than the TAR region (Fig. 3A) . Given the steep transcriptional polarity in the absence of Tat, and the fact that only prematurely terminated transcripts that contain the TAR RNA stem-loop are stable in cells (17, 19, 22) , the second set of primers (1 and 3) should detect very few, if any, prematurely terminated transcripts. Both sets of primers amplified with equal efficiencies in vitro transcribed RNA and plasmid DNA and were sensitive to <100 copies of nucleic acid (Fig. 3B and data not shown) .
Ratios of short to long transcripts were assessed by comparing autoradiographs of amplified DNA obtained with both sets of primers (Fig. 3B, left) . Nonactivated U1 cells transcribed predominantly short transcripts (Fig. 3B, righthand  panel) . This correlated with the low levels of doubly spliced transcripts in U1 cells (Fig. 2B, lane 1) . However, 4 and 8 days after infection with amphotropic retroviruses coding for Tat (Fig. 1) , ratios of short to long transcripts decreased by 10-to 100-fold (Fig. 3B, central panels) . Moreover, 4 days after the administration of PHA/PMA, the ratios of short to long transcripts decreased similarly (Fig. 3B, righthand (Fig. 1) ; Tat d8, U1 cells 8 days after infection with LtatSN; PHA/PMA d4, U1 cells 4 days after stimulation with PHA and PMA. Ratios ofthe long transcripts (LT) to short transcripts (ST) are given below each lane. infected individuals. To this end, RNA and DNA were extracted from PBMCs of 9 HIV-1-infected individuals with high CD4 levels (CD4 cells per mm3 ranged from 1051 to 502, with a median level of 620). None of these individuals was viremic, and all were asymptomatic except for oral candida in two individuals.
In all nine cases, viral DNA could be amplified from cells of these individuals with both primer pair 1 and 3 ( Fig. 4C ) and primer pair 1 and 2 (Fig. 4D) . This indicates that the PBMCs of each individual harbored HIV-infected cells. Moreover, in all nine cases the presence of promoterproximal transcripts (short transcripts) could be readily detected (Fig. 4B) in the absence of promoter-distal transcription (Fig. 4A) . Controls of the reactions without reverse transcriptase verified that the promoter-proximal signal was due to RNA rather than DNA (Fig. 4B, lanes marked with a  minus sign) . This result indicates all (9/9) of these non-AIDS individuals with high CD4 counts harbored latent proviruses that were transcriptionally active, but deficient in transcription elongation.
To determine if, as in U1 cells, activation of latently infected cells could change the ratio of promoter-proximal to Proc. Natl. Acad. Sci promoter-distal transcription, the PBMC with a CD4 count of 420 were activated autologous cells in the presence of PHA promoter-proximal transcripts could be uncultured cells (Fig. 5, day 0) . Howevc ratios of short to long transcripts decline 5, day 3 and day 14). Increased levels oflo also correlated with the appearance oi supernatants (undetectable at day 0; 9 pg/ CD4 COUNT 420
Is of one individual on days 3 and 14 after cellular activation, respectively). RNA I by coculture with was also extracted from PBMCs of two AIDS patients with As in Fig. 4 , only CD4 counts of 10 and 36 (Fig. 5) . As expected, because of detected in these increased levels of viral replication observed late in the or, after activation, disease (23, 24) , the ratio of short to long transcripts in these A to <10-fold (Fig. patients approached one (Fig. 5) . Promoter-distal transcripts )ng transcripts were could also be detected in the PBMCs of an asymptomatic and f p24w* in culture p24w negative individual with a CD4 count of 412 (Fig. 5) Fig. 3 transcripts could be detected in the absence of promoterdistal transcripts. In Ul cells, and in the PBMCs of an asymptomatic HIV-1-infected individual, cellular activation correlated with decreased ratios of short to long transcripts and new synthesis of viral proteins. We also observe this phenotype in AIDS patients and in one HIV-infected individual with an intermediate CD4 level (Fig. 5) . It is possible that detection of promoter-distal transcripts might be a reflection ofthe escape of the activated infected cells from the lymph nodes and, therefore, detection ofpromoter-distal transcripts might be a sensitive marker for the destruction ofthe follicular dendritic cell networks that occurs early in disease progression (reviewed in ref. 27 ).
Various mechanisms have been proposed to explain the regulation of assembly of elongation-competent polymerase complexes (28) . Presumably, in latently infected cells that transcribe only promoter-proximal viral RNA, the basal levels of NF-KB (or other transcription factors that act on the LTR) are so low that levels ofTat are not reached that would affect a change from promoter-proximal to promoter-distal transcription. This might occur in T cells that were once activated such that viral integration occurred (25, 29) but then became quiescent and part ofthe pool of infected "memory" T cells. Indeed, these T cells as defined by the CD45RO marker contain abundant proviral DNA (30, 31) . Activation of these cells by antigen would increase the basal level of transcription from the LTR, which, in turn, would increase the level of Tat and activate proviral expression. Given that increased levels of viremia are observed late in the disease (23, 24) , it is possible that transcriptional activation of these latent proviruses in the periphery plays a role in T-cell depletion and in the progression to AIDS. 
